Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/56299
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSallustio, B.-
dc.contributor.authorDavies, B.-
dc.contributor.authorColler, J.-
dc.contributor.authorJames, H.-
dc.contributor.authorGillis, D.-
dc.contributor.authorSomogyi, A.-
dc.date.issued2003-
dc.identifier.citationTherapeutic Drug Monitoring, 2003; 25(4):519-519-
dc.identifier.issn0163-4356-
dc.identifier.urihttp://hdl.handle.net/2440/56299-
dc.description.statementofresponsibilitySallustio, BC; Davies, BJL; Coller, JK; James, HM; Gillis, D. and Somogyi, AA-
dc.description.urihttp://apps.isiknowledge.com/summary.do?qid=1&product=WOS&SID=S138aPlEnpLJ4GkAo19&search_mode=GeneralSearch-
dc.language.isoen-
dc.publisherLippincott Williams & Wilkins-
dc.titleRelationship between CYP2D6 genotype and plasma OH-perhexiline/perhexiline concentration ratio in angina patients.-
dc.typeJournal article-
pubs.publication-statusPublished-
dc.identifier.orcidSallustio, B. [0000-0002-0186-3073]-
dc.identifier.orcidColler, J. [0000-0002-8273-5048]-
dc.identifier.orcidSomogyi, A. [0000-0003-4779-0380]-
Appears in Collections:Aurora harvest 5
Pharmacology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.